Literature DB >> 9624610

Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.

L Cuomo1, P Trivedi, U de Grazia, A Calogero, M D'Onofrio, W Yang, L Frati, A Faggioni, L Rymo, G Ragona.   

Abstract

The effect of HHV-6 strain A infection on the expression of Epstein-Barr virus- (EBV-) encoded growth transformation-associated genes in two EBV-positive Burkitt lymphoma cell lines, Akata and P3HR-3, was investigated. The results indicate that HHV-6A upregulates the expression of the latent membrane protein LMP-1 in both cell lines. Expression of EBNA-2 was also upregulated in Akata cells following HHV-6A infection. Transfection of reporter constructs carrying the LMP-1 regulatory sequences (LRS; -634/+40) or its 5' deleted derivatives in Akata and in a T-lymphoblastoid cell line, J-Jhan, confirmed the presence of positive and negative regulatory elements responsive to HHV-6A infection in LMP-1 regulatory sequence (LRS). The majority of LRS constructs were under the influence of dominant negative factors. HHV-6A was able to override the effect of such factors acting on reporter plasmids containing the -634/-54, -324/-54, -214/-54, and -106/-54 parts of LRS. The plasmid that carried only the -54/+40 LRS region was constitutively active in both Akata and J-Jhan cells; in Akata, its activity was influenced by HHV-6A. The finding that HHV-6A infection may activate LMP-1 and EBNA-2 expression, which is essential for the immortalization of B-lymphocytes by EBV, shows a novel aspect of the interaction between these two herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624610

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  U20 is responsible for human herpesvirus 6B inhibition of tumor necrosis factor receptor-dependent signaling and apoptosis.

Authors:  Emil Kofod-Olsen; Katrine Ross-Hansen; Mariane Høgsbjerg Schleimann; Dea Kejlberg Jensen; Janni Michelle Lund Møller; Bettina Bundgaard; Jacob Giehm Mikkelsen; Per Höllsberg
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

3.  Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients.

Authors:  F Falasca; P Maida; A Gaeta; S Verzaro; I Mezzaroma; A Fantauzzi; G Donato; E Bonci; C Castilletti; G Antonelli; O Turriziani
Journal:  Infection       Date:  2014-10-18       Impact factor: 3.553

Review 4.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 5.  Multiple sclerosis: an example of pathogenic viral interaction?

Authors:  Walter Fierz
Journal:  Virol J       Date:  2017-02-28       Impact factor: 4.099

Review 6.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

7.  Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.

Authors:  Elin Engdahl; Rasmus Gustafsson; Jesse Huang; Martin Biström; Izaura Lima Bomfim; Pernilla Stridh; Mohsen Khademi; Nicole Brenner; Julia Butt; Angelika Michel; Daniel Jons; Maria Hortlund; Lucia Alonso-Magdalena; Anna Karin Hedström; Louis Flamand; Masaru Ihira; Tetsushi Yoshikawa; Oluf Andersen; Jan Hillert; Lars Alfredsson; Tim Waterboer; Peter Sundström; Tomas Olsson; Ingrid Kockum; Anna Fogdell-Hahn
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

8.  Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls.

Authors:  Cheng-Te Major Lin; Emily C Leibovitch; M Isabel Almira-Suarez; Steven Jacobson
Journal:  Infect Agent Cancer       Date:  2016-07-26       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.